Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 with financial backing from the commercial insurance unit of the Swiss Re ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday. The company’s shares closed yesterday at $401.36.
Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 report. The firm says it still struggles to understand ...
Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice ...
The market outlook is as uncertain as it gets. On January 18, Robert Pavlik, senior portfolio manager at Dakota Wealth Management, appeared in an interview on Wealth at Yahoo Finance to share his ...
Elevance Health ELV has outperformed the market over the past 20 years by 1.37% on an annualized basis producing an average annual return of 9.81%. Currently, Elevance Health has a market ...
Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions ...
View Our Latest Analysis on ELV Elevance Health Price Performance Elevance Health stock opened at $388.93 on Thursday. Elevance Health, Inc. has a 12 month low of $362.21 and a 12 month high of ...
S&P 500 notches closing record with focus on Trump comments, earnings January 24, 2025 Elevance Health on Thursday posted a better-than-feared fourth-quarter profit, which came as a relief to ...
Oakmark Equity and Income Fund highlighted stocks like Elevance Health, Inc. (NYSE:ELV) in the fourth quarter 2024 investor letter. Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...
Oakmark Equity and Income Fund highlighted stocks like Elevance Health, Inc. (NYSE:ELV) in the fourth quarter 2024 investor letter. Elevance Health, Inc. (NYSE:ELV) is a health benefits company that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results